Nyxoah (NYXH) Competitors $8.91 -2.42 (-21.36%) Closing price 03/26/2025 04:00 PM EasternExtended Trading$8.99 +0.08 (+0.95%) As of 03/26/2025 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NYXH vs. TNDM, LQDA, INMD, CDRE, BLFS, KMTS, MDXG, ESTA, FNA, and EYEShould you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include Tandem Diabetes Care (TNDM), Liquidia (LQDA), InMode (INMD), Cadre (CDRE), BioLife Solutions (BLFS), Kestra Medical Technologies (KMTS), MiMedx Group (MDXG), Establishment Labs (ESTA), Paragon 28 (FNA), and National Vision (EYE). These companies are all part of the "medical equipment" industry. Nyxoah vs. Tandem Diabetes Care Liquidia InMode Cadre BioLife Solutions Kestra Medical Technologies MiMedx Group Establishment Labs Paragon 28 National Vision Nyxoah (NASDAQ:NYXH) and Tandem Diabetes Care (NASDAQ:TNDM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations, community ranking and institutional ownership. Which has preferable valuation & earnings, NYXH or TNDM? Nyxoah has higher earnings, but lower revenue than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNyxoah$4.52M67.13-$46.77M-$1.95-4.57Tandem Diabetes Care$940.20M1.39-$222.61M-$1.46-13.47 Does the media refer more to NYXH or TNDM? In the previous week, Tandem Diabetes Care had 3 more articles in the media than Nyxoah. MarketBeat recorded 8 mentions for Tandem Diabetes Care and 5 mentions for Nyxoah. Tandem Diabetes Care's average media sentiment score of 1.36 beat Nyxoah's score of 0.31 indicating that Tandem Diabetes Care is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nyxoah 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tandem Diabetes Care 4 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in NYXH or TNDM? Tandem Diabetes Care received 547 more outperform votes than Nyxoah when rated by MarketBeat users. However, 72.73% of users gave Nyxoah an outperform vote while only 61.02% of users gave Tandem Diabetes Care an outperform vote. CompanyUnderperformOutperformNyxoahOutperform Votes4072.73% Underperform Votes1527.27% Tandem Diabetes CareOutperform Votes58761.02% Underperform Votes37538.98% Is NYXH or TNDM more profitable? Tandem Diabetes Care has a net margin of -14.84% compared to Nyxoah's net margin of -1,043.93%. Tandem Diabetes Care's return on equity of -44.19% beat Nyxoah's return on equity.Company Net Margins Return on Equity Return on Assets Nyxoah-1,043.93% -51.68% -40.11% Tandem Diabetes Care -14.84%-44.19%-11.99% Do analysts rate NYXH or TNDM? Nyxoah currently has a consensus price target of $14.75, suggesting a potential upside of 65.54%. Tandem Diabetes Care has a consensus price target of $45.38, suggesting a potential upside of 130.80%. Given Tandem Diabetes Care's higher possible upside, analysts clearly believe Tandem Diabetes Care is more favorable than Nyxoah.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Tandem Diabetes Care 0 Sell rating(s) 7 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.61 Which has more volatility & risk, NYXH or TNDM? Nyxoah has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500. SummaryTandem Diabetes Care beats Nyxoah on 11 of the 16 factors compared between the two stocks. Remove Ads Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NYXH vs. The Competition Export to ExcelMetricNyxoahSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$303.48M$4.42B$5.63B$8.15BDividend YieldN/A32.62%4.55%4.00%P/E Ratio-4.7628.7924.5019.08Price / Sales67.1349.55385.2994.58Price / CashN/A51.0838.1634.64Price / BookN/A6.166.954.36Net Income-$46.77M$67.64M$3.20B$247.23M7 Day Performance-19.37%-0.66%-2.42%-0.61%1 Month Performance-11.03%-2.43%2.18%-5.12%1 Year Performance-33.36%19.33%12.85%3.60% Nyxoah Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NYXHNyxoah2.7207 of 5 stars$8.91-21.4%$14.75+65.5%-33.4%$303.48M$4.52M-4.76110Analyst ForecastShort Interest ↓Gap DownHigh Trading VolumeTNDMTandem Diabetes Care4.6176 of 5 stars$20.62+1.6%$45.38+120.1%-41.6%$1.37B$940.20M-10.682,400Positive NewsLQDALiquidia2.4979 of 5 stars$15.66+3.6%$26.63+70.0%-6.6%$1.34B$14.00M-9.6150Earnings ReportAnalyst RevisionINMDInMode1.5438 of 5 stars$19.00+2.0%$22.25+17.1%-11.9%$1.32B$394.82M8.09480News CoverageCDRECadre3.0878 of 5 stars$31.50+1.0%$37.00+17.5%-15.1%$1.28B$567.56M37.952,240Insider TradeBLFSBioLife Solutions1.3192 of 5 stars$26.41+5.7%$29.86+13.1%+40.9%$1.24B$82.25M-24.92440Positive NewsKMTSKestra Medical TechnologiesN/A$24.50-1.8%N/AN/A$1.21B$45.82M0.00300MDXGMiMedx Group3.3516 of 5 stars$8.10+2.0%$12.00+48.1%+0.3%$1.19B$348.88M14.73870Positive NewsESTAEstablishment Labs2.3987 of 5 stars$41.22+3.9%$57.40+39.3%-19.7%$1.19B$166.03M-15.98960FNAParagon 281.3796 of 5 stars$13.02+0.0%$14.20+9.1%+26.9%$1.09B$256.18M-17.59343,000High Trading VolumeEYENational Vision1.259 of 5 stars$13.61+4.5%$14.00+2.9%-38.8%$1.07B$1.82B-68.0514,000Short Interest ↑ Remove Ads Related Companies and Tools Related Companies Tandem Diabetes Care Competitors Liquidia Competitors InMode Competitors Cadre Competitors BioLife Solutions Competitors Kestra Medical Technologies Competitors MiMedx Group Competitors Establishment Labs Competitors Paragon 28 Competitors National Vision Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NYXH) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nyxoah With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NYXH Stock Free NYXH Stock Alerts